The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
New Testing Strategy to Detect Early HIV-1 Infection for Use in Incidence Estimates and for Clinical and Prevention Purposes
Abstract
CONTEXT: Differentiating individuals with early human immunodeficiency virus 1 (HIV-1) infection from those infected for longer periods is difficult but important for estimating HIV incidence and for purposes of clinical care and prevention. OBJECTIVE: To develop and validate a serologic testing algorithm in which HIV-1-positive persons with reactive test results on a sensitive HIV-1 enzyme immunoassay (EIA) but nonreactive results on a less sensitive (LS) EIA are identified as having early infection. DESIGN: Diagnostic test and testing strategy development, validation, and application. Specimens were tested with both a sensitive HIV-1 EIA (3A11 assay) and a less sensitive modification of the same EIA (3A11-LS assay). SETTINGS AND PARTICIPANTS: For assay development: 104 persons seroconverting to HIV-1 comprising 38 plasma donors, 18 patients of a sexually transmitted disease clinic in Trinidad, and 48 participants in the San Francisco Men's Health Study (SFMHS); 268 men without the acquired immunodeficiency syndrome (AIDS) in the SFMHS who had been infected for at least 2.5 years; and 207 persons with clinical AIDS; for testing strategy validation: 488 men in the SFMHS from 1985 through 1990 and 1275449 repeat blood donors at 3 American Red Cross blood centers from 1993 through 1995; and for HIV-1 incidence estimates: 2717910 first-time blood donors. We retrospectively identified persons eligible for a study of early infection. MAIN OUTCOME MEASURE: Ability to identify early HIV infection. RESULTS: Estimated mean time from being 3A11 reactive/3A11-LS nonreactive to being 3A11 reactive/3A11-LS reactive was 129 days (95% confidence interval [CI], 109-149 days) [corrected]. Our testing strategy accurately diagnosed 95% of persons with early infection; however, 0.4% (1/268) of men with established infection and 2% (5/207) of persons with late-stage AIDS were misdiagnosed as having early HIV-1 infection. Average yearly incidence estimates in SFMHS subjects were 1.5% per year vs observed average incidence of 1.4 per 100 person-years. Incidence in repeat blood donors using the sensitive/less sensitive assay testing strategy was 2.95 per 100000 per year (95% CI, 1.14-6.53/100000) vs observed incidence of 2.60 per 100000 person-years (95% CI, 1.49-4.21/100000). Overall incidence in first-time blood donors was 7.18 per 100000 per year (95% CI, 4.51-11.20/100000) and did not change statistically significantly between 1993 and 1996. Use of the sensitive/less sensitive testing strategy alone would have identified all 17 persons with antibodies to HIV-1 eligible for a study of early HIV-1 infection and would have increased enrollment. CONCLUSIONS: The sensitive/less sensitive testing strategy provides accurate diagnosis of early HIV-1 infection, provides accurate estimates of HIV-1 incidence, can facilitate clinical studies of early HIV-1 infection, and provides information on HIV-1 infection duration for care planning.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maximum Likelihood from Incomplete Data Via the EM Algorithm
Dempster, A. P., Laird, N. M., & Rubin, D. B. (1977) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1977.tb01600.x · Cited by 50,444
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500
SNEDECOR, G. W. (1939) · Soil Science · doi:10.1097/00010694-193902000-00006 · Cited by 19,359
Snedecor, G. W., & Cochran, W. G. (1967) · Cited by 6,573
Castro, K. G., Ward, J. W., Slutsker, L., Buehler, J. W., Jaffe, H. W., Berkelman, R. L., & Curran, J. W. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.4.802 · Cited by 4,349
HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time
Perelson, A. S., Neumann, A. U., Markowitz, M., Leonard, J. M., & Ho, D. D. (1996) · Science · doi:10.1126/science.271.5255.1582 · Cited by 3,531
Graphical Methods for Data Analysis.
Healy, M. J. R., Chambers, J. M., Cleveland, W. S., Kleiner, B., & Tukey, P. A. (1984) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2981587 · Cited by 2,315
Graphical Methods for Data Analysis.
Fisher, N. I., Chambers, J. M., Cleveland, W. S., Kleiner, B., & Tukey, P. A. (1984) · Biometrics · doi:10.2307/2531418 · Cited by 1,982
Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia
Rosenberg, E. S., Billingsley, J. M., Caliendo, A. M., Boswell, S. L., Sax, P. E., Kalams, S. A., & Walker, B. D. (1997) · Science · doi:10.1126/science.278.5342.1447 · Cited by 1,835
The Empirical Distribution Function with Arbitrarily Grouped, Censored and Truncated Data
Turnbull, B. W. (1976) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1976.tb01597.x · Cited by 1,828
High Levels of HIV-1 in Plasma During All Stages of Infection Determined By Competitive PCR
Piatak, M., Saag, M. S., Yang, L. C., Clark, S. J., Kappes, J. C., Luk, K.-C., Hahn, B. H., Shaw, G. M., & Lifson, J. D. (1993) · Science · doi:10.1126/science.8096089 · Cited by 1,237
(1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-86-6-835_3 · Cited by 1,155
Quantitation of HIV-1 RNA in Plasma Predicts Outcome after Seroconversion
Mellors, J. W., Kingsley, L. A., Rinaldo, C. R., Todd, J. A., Hoo, B. S., Kokka, R. P., & Gupta, P. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-8-199504150-00003 · Cited by 917
Carpenter, C. C. J. (1997) · JAMA · doi:10.1001/jama.1997.03540480062040 · Cited by 725
Clinical and epidemiologic features of primary HIV infection.
Schacker, T., Collier, A. C., Hughes, J., Shea, T., & Corey, L. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-4-199608150-00001 · Cited by 703 · cited 2×
“Trinidad STD clinic 18 149 16 (5-686) 342 (88-767)”
High Titers of Cytopathic Virus in Plasma of Patients with Symptomatic Primary HIV-1 Infection
Clark, S. J., Saag, M. S., Decker, W. D., Campbell-Hill, S., Roberson, J. L., Veldkamp, P. J., Kappes, J. C., Hahn, B. H., & Shaw, G. M. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104043241404 · Cited by 689
Time to Hit HIV, Early and Hard
Ho, D. D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508173330710 · Cited by 431
Busch, M. P., Lee, L. L. L., Satten, G. A., et al. (1995) · Transfusion · doi:10.1046/j.1537-2995.1995.35295125745.x · Cited by 364
A Controlled Trial of Zidovudine in Primary Human Immunodeficiency Virus Infection
Kinloch-de Loës, S., Hirschel, B. J., Hoen, B., Cooper, D. A., Tindall, B., Carr, A., Saurat, J.-H., Clumeck, N., Lazzarin, A., Mathiesen, L., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508173330702 · Cited by 307
Role of the Primary Infection in Epidemics of HIV Infection in Gay Cohorts
Jacquez, J. A., Koopman, J. S., Simon, C. P., & Longini, I. M. (1995) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199505010-00020 · Cited by 296
Silverman, B. W., Jones, M. C., Wilson, J. D., & Nychka, D. W. (1990) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1990.tb01788.x · Cited by 274
Winkelstein, W., Samuel, M., Padian, N. S., Wiley, J. A., Lang, W., Anderson, R. E., & Levy, J. A. (1987) · American Journal of Public Health · doi:10.2105/ajph.77.6.685 · Cited by 264
Reconstruction and Future Trends of the AIDS Epidemic in the United States
Brookmeyer, R. (1991) · Science · doi:10.1126/science.2063206 · Cited by 257
Tindall, B. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.148.4.945 · Cited by 249
Winkelstein, W. (1987) · JAMA · doi:10.1001/jama.1987.03390030051019 · Cited by 240
Jarlais, D. C. D. (1994) · JAMA · doi:10.1001/jama.271.2.121 · Cited by 192
Scope of the AIDS Epidemic in the United States
Rosenberg, P. S. (1995) · Science · doi:10.1126/science.270.5240.1372 · Cited by 178
Symptomatic Primary Infection Due to Human Immunodeficiency Virus Type 1: Review of 31 Cases
Kinloch-de Loes, S., de Saussure, P., Saurat, J.-H., Stalder, H., Hirschel, B., & Perrin, L. H. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.1.59 · Cited by 169
Niu, M. T., Stein, D. S., & Schnittman, S. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/168.6.1490 · Cited by 151
Pantaleo, G., Cohen, O. J., Schacker, T., Vaccarezza, M., Graziosi, C., Rizzardi, G. P., Kahn, J., Fox, C. H., Schnittman, S. M., Schwartz, D. H., et al. (1998) · Nature Medicine · doi:10.1038/nm0398-341 · Cited by 132
Quinn, T. C. (1997) · JAMA · doi:10.1001/jama.1997.03550010072043 · Cited by 123
The Retrovirus Epidemiology Donor Study (REDS): rationale and methods
Zuck, T. F., Thomson, R. A., Schreiber, G. B., Gilcher, R. O., Kleinman, S. H., Murphy, E. L., Ownby, H. E., WILLIAMS, A. E., Busch, M. P., Smith, J. W., et al. (1995) · Transfusion · doi:10.1046/j.1537-2995.1995.351196110900.x · Cited by 90
Commentary: The Relevance of Social Network Concepts to Sexually Transmitted Disease Control
ROTHENBERG, R. B., & Narramore, J. (1996) · Sexually Transmitted Diseases · doi:10.1097/00007435-199601000-00007 · Cited by 81
Temporal Trends in Human Immunodeficiency Virus type 1 Seroconversion 1984–1989
Kingsley, L., Zhou, S., Bacellar, H., et al. (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116094 · Cited by 81
False‐positive human immunodeficiency virus type 1 western blot tests in noninfected blood donors
Sayre, K. R., Dodd, R. Y., Tegtmeier, G. E., Layug, L., Alexander, S. S., & Busch, M. P. (1996) · Transfusion · doi:10.1046/j.1537-2995.1996.36196190514.x · Cited by 73
O'Brien, T. R., Busch, M. P., Donegan, E. A., Ward, J. W., Wong, L.-Y., Samson, S., Perkins, H. A., Altman, R., Stoneburner, R. L., & Holmberg, S. D. (1994) · PubMed · Cited by 66
Brookmeyer, R., Quinn, T. C., Shepherd, M., Mehendale, S. M., Rodrigues, J. J., & Bollinger, R. C. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117700 · Cited by 61
Cited by
Estimation of HIV Incidence in the United States
Hall, H. I. (2008) · JAMA · doi:10.1001/jama.300.5.520 · Cited by 1,317
Fiebig, E. W., Wright, D. J., Rawal, B. D., Garrett, P. E., Schumacher, R. T., Peddada, L., Heldebrant, C., Smith, R., Conrad, A., Kleinman, S. H., et al. (2003) · AIDS · doi:10.1097/00002030-200309050-00005 · Cited by 1,305
Mehandru, S., Poles, M. A., Tenner-Racz, K., Horowitz, A., Hurley, A., Hogan, C., Boden, D., Racz, P., & Markowitz, M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041196 · Cited by 1,146
Antiretroviral-Drug Resistance among Patients Recently Infected with HIV
Little, S. J., Holte, S., Routy, J.-P., Daar, E. S., Markowitz, M., Collier, A. C., Koup, R. A., Mellors, J. W., Connick, E., Conway, B., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013552 · Cited by 1,140
Estimated HIV Incidence in the United States, 2006–2009
Prejean, J., Song, R., Hernandez, A., Ziebell, R., Green, T., Walker, F., Lin, L. S., An, Q., Mermin, J., Lansky, A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017502 · Cited by 1,071
Metadata
- Authors
- Janssen, R. S.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 1998-07-01
- Volume
- 280
- Issue
- 1
- Pages
- 42
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2108603500
- Cited by
- 687
- References
- 37
- FWCI
- 23.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.